The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042
- Hermida-Prado, F.
- Villaronga, M.Á.
- Granda-Díaz, R.
- Del-Río-Ibisate, N.
- Santos, L.
- Hermosilla, M.A.
- Oro, P.
- Allonca, E.
- Agorreta, J.
- Garmendia, I.
- Tornín, J.
- Perez-Escuredo, J.
- Fuente, R.
- Montuenga, L.M.
- Morís, F.
- Rodrigo, J.P.
- Rodríguez, R.
- García-Pedrero, J.M.
Aldizkaria:
Journal of Clinical Medicine
ISSN: 2077-0383
Argitalpen urtea: 2019
Alea: 8
Zenbakia: 8
Mota: Artikulua
